SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000936392-07-000956
Filing Date
2007-12-19
Accepted
2007-12-19 16:54:52
Documents
5
Period of Report
2007-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a36637e8vk.htm 8-K 14886
2 EXHIBIT 10.1 a36637exv10w1.htm EX-10.1 111400
3 GRAPHIC a36637a3663701.gif GRAPHIC 57869
4 GRAPHIC a36637a3663702.gif GRAPHIC 48516
5 GRAPHIC a36637a3663703.gif GRAPHIC 51346
  Complete submission text file 0000936392-07-000956.txt   345721
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 071316808
SIC: 2834 Pharmaceutical Preparations